β- and γ-melanocortins inhibit lipopolysaccharide induced nitric oxide production in mice brain

Brain Research

Volumn 995, Issue 1, 2004, Pages 7-13

  Muceniece, Ruta ^a   Zvejniece, Liga ^a,b   Kirjanova, Olga ^b   Liepinsh, Edgars ^a,b   Krigere, Liga ^a   Baumane, Larisa ^b   Kalvinsh, Ivars ^b   Wikberg, Jarl E S ^c   Dambrova, Maija ^b  

^a UNIVERSITY OF LATVIA   (Latvia)

^b LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Brain inflammation; Electron paramagnetic resonance; Lipopolysaccharide; Melanocortin; Nitric oxide

Indexed keywords

ALPHA INTERMEDIN; AUTACOID; BETA INTERMEDIN; GAMMA INTERMEDIN; LIPOPOLYSACCHARIDE; MELANOCORTIN; NITRIC OXIDE;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; ELECTRON SPIN RESONANCE; FEEDBACK SYSTEM; IN VIVO STUDY; INFLAMMATION; MALE; METABOLISM; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0344440819     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2003.09.039     Document Type: Article

References (36)

1. Airaghi L., Lettino M., Manfredi M.G., Lipton J.M., Catania A. Endogenous cytokine antagonists during myocardial ischemia and thrombolytic therapy. Am. Heart J. 130:1995;204-211.
2. Baumane L., Dzintare M., Zvejniece L., Meirena D., Lauberte L., Sile V., Kalvinsh I., Sjakste N. Increased synthesis of nitric oxide in rat brain cortex due to halogenated volatile anesthetics confirmed by EPR spectroscopy. Acta Anaesthesiol. Scand. 46:2002;378-383.
3. Bertagna X. Proopiomelanocortin-derived peptides. Endocrinol. Metab. Clin. N. Am. 23:1994;467-485.
4. Catania A., Gerloni V., Procaccia S., Airaghi L., Manfredi M.G., Lomater C., Grossi L., Lipton J.M. The anticytokine neuropeptide alpha-melanocyte- stimulating hormone in synovial fluid of patients with rheumatic diseases: comparisons with other anticytokine molecules. Neuroimmunomodulation. 1:1994;321-328.
5. Catania A., Suffredini A.F., Lipton J.M. Endotoxin causes release of alpha-melanocyte-stimulating hormone in normal human subjects. Neuroimmunomodulation. 2:1995;258-262.
6. Catania A., Cutuli M., Garofalo L., Carlin A., Airaghi L., Barcellini W., Lipton J.M. The neuropeptide alpha-MSH in host defense. Ann. N.Y. Acad. Sci. 917:2000;227-231.
7. Chiao H., Foster S., Thomas R., Lipton J., Star R.A. Alpha-melanocyte- stimulating-hormone reduces endotoxin-induced liver inflammation. J. Clin. Invest. 97:1996;2038-2044.
8. Delgado R., Carlin A., Airaghi L., Demitri M.T., Meda L., Galimberti D., Baron P., Lipton J.M., Catania A. Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia. J. Leukoc. Biol. 63:1998;740-745.
9. Delgado Hernandez R., Demitri M.T., Carlin A., Meazza C., Villa P., Ghezzi P., Lipton J.M., Catania A. Inhibition of systemic inflammation by central action of the neuropeptide alpha-melanocyte-stimulating hormone. Neuroimmunomodulation. 6:1999;187-192.
10. Denko C.W., Gabriel P. Effects of peptide hormones in urate crystal inflammation. J. Rheumatol. 12:1985;971-975.
11. Eberle A.N. The Melanotropins; Chemistry, Physiology and Mechanisms of Action. 1988;Karger, Basel, Switzerland.
12. Galimberti D., Baron P., Meda L., Prat E., Scarpini E., Delgado R., Catania A., Lipton J.M., Scarlato G. Alpha-MSH peptides inhibit production of nitric o1xide and tumor necrosis factor-alpha by microglial cells activated with beta-amyloid and interferon gamma. Biochem. Biophys. Res. Commun. 263:1999;251-256.
13. Getting S.J., Alleock G.H., Flower R., Perretti M. Natural and synthetic agonists of the melanocortin receptor type 3 possess anti-inflammatory properties. J. Leukoc. Biol. 69:2001;98-104.
14. Getting S.J., Christian H.C., Lam C.W., Gavins F.N., Flower R.J., Schioth H.B., Perretti M. Redundancy of a functional melanocortin 1 receptor in the anti-inflammatory actions of melanocortin peptides: studies in the recessive yellow (e/e) mouse suggest an important role for melanocortin 3 receptor. J. Immunol. 170:2003;3323-3330.
15. Guarini S., Bazzani C., Cainazzo M.M., Mioni C., Ferrazza G., Vergoni A.V., Schioth H.B., Wikberg J.E.S., Bertolini A. Evidence that melanocortin 4 receptor mediates hemorrhagic shock reversal caused by melanocortin peptides. J. Pharmacol. Exp. Ther. 291:1999;1023-1027.
16. Heneka M.T., Dumitrescu L., Loschmann P.A., Wullner U., Klockgether T. Temporal, regional, and cell-specific changes of iNOS expression after intrastriatal microinjection of interferon gamma and bacterial lipopolysaccharide. J. Chem. Neuroanat. 18:2000;167-179.
17. Ichiyama T., Sakai T., Catania A., Barsh G.S., Furukawa S., Lipton J.M. Systematically administered-melanocyte-stimulating peptides inhibit NF-κ activation in experimental brain inflammation. Brain Res. 836:1999;31-37.
18. Ichiyama T., Zhao H., Catania A., Furukawa S., Lipton J.M. Melanocyte-stimulating hormone inhibits NF-κ activation and IB degradation in human glioma cells and in experimental brain inflammation. Exp. Neurol. 157:1999;359-365.
19. 3 receptor in the regulation of food intake. Neurosci. Lett. 283:2000;1-4.
20. Klusa V., Germane S., Svirskis S., Wikberg J.E. The gamma(2)-MSH peptide mediates a central analgesic effect via a GABA-ergic mechanism that is independent from activation of melanocortin receptors. Neuropeptides. 35:2001;50-57.
21. Lipton J.M., Catania A. Anti-inflammatory actions of the neuroimmunomodulator α-MSH. Immunol. Today. 18:1997;140-145.
22. Lipton J.M., Zhao H., Ichiyama T., Barsh G.S., Catania A. Mechanisms of antiinflammatory action of alpha-MSH peptides. In vivo and in vitro evidence. Ann. N.Y. Acad. Sci. 885:1999;173-182. (Review).
23. Luger T.A., Brzoska T., Scholzen T.E., Kalden D.H., Sunderkotter C., Armstrong C., Ansel J. The role of alpha-MSH as a modulator of cutaneous inflammation. Ann. N.Y. Acad. Sci. 917:2000;232-238.
24. Mandrika I., Muceniece R., Wikberg J.E.S. Effects of melanocortin peptides on lipopolysaccharide/interferon-gamma-induced NF-κ DNA binding and nitric oxide production in macrophage-like RAW 264.7: evidence for dual mechanisms of action. Biochem. Pharmacol. 61:2001;613-621.
25. Manna S.K., Aggarwal B.B. Melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-κB activation induced by various inflammatory agents. J. Immunol. 161:1998;2873-2880.
26. Mattson M.P., Camandola S. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. 107:2001;247-254.
27. 2+ with diethylthiocarbomate of N-methyl-D-glucamine dithiocarbomate as traps of nitric oxide in animal tissues: comparative investigations. Biochim. Biophys. Acta. 1336:1997;225-234.
28. Nijsen Mj., de Ruiter G.J., Kasbergen C.M., Hoogerhout P., de Widt D.J. Relevance of the C-terminal arg-Phe sequence in gamma(2)-melanocyte-stimulating hormone (gamma(2)-MSH) for inducing cardiovascular effects in conscious rats. Br. J. Pharmacol. 131:2000;1468-1474.
29. Rajora N., Boccoli G., Catania A., Lipton J.M. Alpha-MSH modulates experimental inflammatory bowel disease. Peptides. 18:1997;381-385.
30. Schioth H.B., Muceniece R., Wikberg J.E.S., Chhajlani V. Characterization of melanocortin receptor subtypes by radioligand binding analysis. Eur. J. Pharmacol. 288:1995;311-317.
31. Schioth H.B., Muceniece R., Wikberg J.E.S. Characterisation of melanocortin 4 receptor by radioligand binding analysis. Pharmacol. Toxicol. 79:1996;161-165.
32. Star R.A., Rajora N., Huang J., Stock R.C., Catania A., Lipton J.M. Evidence of autocrine modulation of macrophage nitric oxide synthase by melanocyte-stimulating hormone. Proc. Natl. Acad. Sci. U. S. A. 92:1995;8016-8020.
33. Vanin A.F., Mordvintsev P.I., Kleshchov A.L. Incorporation of nitric oxide in animal organ tissues in vivo. Stud. Biophys. (Rus.). 102:1984;135-143.
34. Vanin A.F., Huisman A., vanFaassen E.E. Iron dithiocarbamate as spin trap for NO detection: pitfalls and successes. Methods Enzymol. 359:2002;27-42.
35. Wikberg J.E.S., Muceniece R., Mandrika I., Prusis P., Lindblom J., Post C., Skottner A. New aspects on the melanocortins and their receptors. Pharmacol. Res. 42:2000;393-420.
36. Xia Y., Wikberg J.E., Krukoff T.L. Gamma(2)-melanocyte-stimulating hormone suppression of systematic inflammatory responses to endotoxin is associated with modulation of central autonomic and neuroendocrine activities. J. Neuroimmunol. 120:2001;67-77.